Sandoz   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Basel Switzerland (1886)
Status: Acquired by Novartis (1996)

Organization Overview

First Clinical Trial
1987
NCT00946491
First Marketed Drug
1946
mephenytoin (mesantoin)
First NDA Approval
1946
mephenytoin (mesantoin)
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

GPP | Sandoz | SANDOZ | Sandoz Biopharmaceutical, Hexal AG, Germany | SANDOZ CANADA INC | Sandoz GmbH | SANDOZ INC | SCOV3